Statistics for BioMerieux (id:10602 BIM)
Valuation metrics
Market cap
11.43B
Enterprise value
11.69B
Trailing P/E (ttm)
27.81
Forward P/E
21.12
PEG ratio
21.12
Price/Sales (ttm)
3.00
Price/Book (mrq)
2.94
Enterprise Value/Revenue
3.07
Enterprise Value/EBITDA
13.53
Overview
Shares outstanding
117.93M
Float
43.73M
Shares short
% Held by insiders
0.64%
% Held by institutions
0.20%
Average volume (10 days)
125.06K
Average volume (90 days)
Price summary
52-Week low
88.25
52-Week high
111.50
52-Week change
-0.62%
Beta
0.22
50-Day moving average
105.15
200-Day moving average
99.98
Dividends and splits
Forward annual dividend rate
3.40
Forward annual dividend yield
0.03
Trailing annual dividend rate
0.85%
Trailing annual dividend yield
0.01
5-Year annual dividend yield
0.63
Payout ratio
0.24
Dividend date
Ex-dividend date
June 07th, 2024
Last split factor
2:1
Last split date
September 20th, 2017
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
10.80%
Operating margin
15.16%
Operational effectiveness
Return on assets
7.08%
Return on equity
10.61%
Income statement
Revenue (ttm)
32.26
Revenue per share (ttm)
32.26
Quarterly revenue growth (yoy)
0.33
Gross profit (ttm)
2.06B
EBITDA
830.40M
Net income to common (ttm)
411.30M
Diluted EPS (ttm)
3.47
Quarterly earnings growth (yoy)
33.20%
Balance sheet
Total cash (mrq)
272.20M
Total cash per share (mrq)
2.31
Total debt (mrq)
558.50M
Total Debt/Equity (mrq)
14.39
Current ratio (mrq)
221.00%
Book value per share (mrq)
32.78
Cash flow
Cash flow statement
494.60M
Levered free cash flow (LFCF)
180.71M